Hims & Hers’ Revenue Beat Came With a Profitability Problem
After recently receiving the unwelcome news about Hims & Hers Health (NYSE: HIMS) being sued by the U.S. Federal Trade Commission (FTC), California, and Utah, investors were dealt another blow on Monday, Aug. 10. The telehealth platform, which provides …